Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)

NCT02655887 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT02655887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02655887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2016
Completion date
October 30, 2020
Enrollment
170 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

iliofemoral occlusive disease, may-thurner syndrome, peripheral vascular disease, venous disease